Trending Now
SPY puts on the rise fearing corona virus
Futures are up at the moment but so is the VIX. The SPY is currently sitting at 337.80 in the premarket after...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Mustang Bio Inc. (NASDAQ:MBIO) Commences Dosing Of Patients With MB-102 And...
Mustang Bio Inc. (NASDAQ:MBIO) has announced the dosing of the first patient in its multicentre, Open-label phase 1/2 study evaluating efficacy and safety of...
MAKE IT MODERN
LATEST REVIEWS
Liquidia Corp (NASDAQ: LQDA) Will Have a Presentation on YUTREPIA
Liquidia Corporation (NASDAQ: LQDA) has announced a presentation on YUTREPIA studies by Dr Samdeep Sahay. The drug, which is still under investigation, is a...
MAKE IT MODERN
PERFORMANCE TRAINING
Acumen Pharmaceutical Inc (NASDAQ: ABOS) Issues an Update on Its Research on ACU193 Compound
Acumen Pharmaceutical Inc (NASDAQ: ABOS) recently announced the publication of a report that advocates for the use of ‘ACU193'. The compound is a monoclonal...
Moderna Inc (NASDAQ:MRNA) says its Experimental COVID-19 Vaccine is Likely to be Effective in...
In its operations for the past nine years, Moderna Inc (NASDAQ:MRNA) has carved a niche for itself in developing novel platforms for manufacturing a...
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Receive The FDA’s Response After Its NDA Submission...
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) recently announced that it received the Food and Drug Administration’s (FDA) complete response letter regarding its New Drug...
Top CBD, Cannabis, and Metaverse Momentum Stories Surface in August Rally (CRON, UBQU, TLRY,...
The rally across the stock market over the past six weeks has been sharp and powerful, driving new money off the sidelines and dealing...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receives European Commission KALYDECO Approval For Treatment Of CF In...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has announced that the company has been granted approval by the European Commission for the KALYDECO (ivacaftor) label extension to...
MAKE IT MODERN
